Elevated phosphorylation of AKT1/2 is observed in 40–50% of bladder cancer cases, independent of PIK3CA or PTEN alterations, and may result from upstream receptor tyrosine kinase (e.g., FGFR3 or EGFR) activation (10, 17). This evidence concerns the gene EGFR and urinary bladder cancer.